Literature DB >> 28916288

Anti-apoptotic and moderate anti-inflammatory effects of berberine in sulfur mustard exposed keratinocytes.

Simon Lang1, Tanja Popp2, Christian Silvester Kriegs3, Annette Schmidt4, Frank Balszuweit5, Georg Menacher6, Kai Kehe7, Horst Thiermann6, Thomas Gudermann8, Dirk Steinritz2.   

Abstract

Skin affections after sulfur mustard (SM) exposure include erythema, blister formation and severe inflammation. An antidote or specific therapy does not exist. Anti-inflammatory compounds as well as substances counteracting SM-induced cell death are under investigation. In this study, we investigated the benzylisoquinoline alkaloide berberine (BER), a metabolite in plants like berberis vulgaris, which is used as herbal pharmaceutical in Asian countries, against SM toxicity using a well-established in vitro approach. Keratinocyte (HaCaT) mono-cultures (MoC) or HaCaT/THP-1 co-cultures (CoC) were challenged with 100, 200 or 300mM SM for 1h. Post-exposure, both MoC and CoC were treated with 10, 30 or 50μM BER for 24h. At that time, supernatants were collected and analyzed both for interleukine (IL) 6 and 8 levels and for content of adenylate-kinase (AK) as surrogate marker for cell necrosis. Cells were lysed and nucleosome formation as marker for late apoptosis was assessed. In parallel, AK in cells was determined for normalization purposes. BER treatment did not influence necrosis, but significantly decreased apoptosis. Anti-inflammatory effects were moderate, but also significant, primarily in CoC. Overall, BER has protective effects against SM toxicity in vitro. Whether this holds true should be evaluated in future in vivo studies.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Berberine; Co-culture; Cytotoxicity; HaCaT; IL-6; IL-8; Pharmaceutical; THP-1

Mesh:

Substances:

Year:  2017        PMID: 28916288     DOI: 10.1016/j.toxlet.2017.09.004

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

Review 1.  Medicinal Species of the Genus Berberis: A Review of Their Traditional and Ethnomedicinal Uses, Phytochemistry and Pharmacology.

Authors:  Zahra Sobhani; Maryam Akaberi; Mohammad Sadegh Amiri; Mahin Ramezani; Seyed Ahmad Emami; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  BMSC-derived exosomes ameliorate sulfur mustard-induced acute lung injury by regulating the GPRC5A-YAP axis.

Authors:  Guan-Chao Mao; Chu-Chu Gong; Zhen Wang; Ming-Xue Sun; Zhi-Peng Pei; Wen-Qi Meng; Jin-Feng Cen; Xiao-Wen He; Ying Lu; Qing-Qiang Xu; Kai Xiao
Journal:  Acta Pharmacol Sin       Date:  2021-03-02       Impact factor: 6.150

3.  Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation.

Authors:  Guanyu Li; Tong Wang; Xiaoyi Zhang; Shurui Zhao; Yaonan Wang; Jianhui Wu; Shiqi Peng; Ming Zhao
Journal:  Drug Des Devel Ther       Date:  2020-06-03       Impact factor: 4.162

4.  Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties.

Authors:  Yongwei Gu; Meng Yang; Xiaomeng Tang; Ting Wang; Dishun Yang; Guangxi Zhai; Jiyong Liu
Journal:  J Nanobiotechnology       Date:  2018-09-15       Impact factor: 10.435

Review 5.  A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.

Authors:  Ahmed T El-Serafi; Ibrahim El-Serafi; Ingrid Steinvall; Folke Sjöberg; Moustafa Elmasry
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

6.  Disentangling the Complexity of a Hexa-Herbal Chinese Medicine Used for Inflammatory Skin Conditions-Predicting the Active Components by Combining LC-MS-Based Metabolite Profiles and in vitro Pharmacology.

Authors:  Jennifer B Chang; Majella E Lane; Min Yang; Michael Heinrich
Journal:  Front Pharmacol       Date:  2018-10-05       Impact factor: 5.810

7.  13-[CH2CO-Cys-(Bzl)-OBzl]-Berberine: Exploring The Correlation Of Anti-Tumor Efficacy With ROS And Apoptosis Protein.

Authors:  Guanyu Li; Yi Ren; Xiaoyi Zhang; Shurui Zhao; Yaonan Wang; Jianhui Wu; Shiqi Peng; Ming Zhao
Journal:  Onco Targets Ther       Date:  2019-12-05       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.